Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

INTRODUCTION: Azilsartan is an angiotensin II receptor blocker indicated for the treatment of patients with hypertension. The efficacy and safety of azilsartan are established in adults, but have not been evaluated in pediatric patients, nor has its pharmacokinetic profile been determined in pediatr...

Descripción completa

Detalles Bibliográficos
Autores principales: Enya, Kazuaki, Saji, Ben T., Kato, Takuya, Okamoto, Hiroyuki, Koumura, Emiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096965/
https://www.ncbi.nlm.nih.gov/pubmed/30027478
http://dx.doi.org/10.1007/s12325-018-0754-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096965/
https://www.ncbi.nlm.nih.gov/pubmed/30027478
http://dx.doi.org/10.1007/s12325-018-0754-5

Ejemplares similares